Screener/Healthcare/Biotechnology

LRMR

Larimar Therapeutics, Inc.NASDAQ
$4.54-0.14 (-2.88%)
Small CapPenny StockUnder $5Healthcare
$1.61
$6.42
$4.47
$4.67
EPS (TTM)$-1.94
P/E Ratio—
Dividend Yield—
Market Cap$480.2M
Volume1.43M
Prev Close$4.68
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$0-$47.7M$-0.61——
Q2 '25$0-$26.2M$-0.41——
Q1 '25$0-$29.3M$-0.46——
Q4 '24$0-$28.8M$-0.46——
Q3 '24$0-$15.5M$-0.24——
Q2 '24$0-$21.6M$-0.34——
Q1 '24$0-$14.7M$-0.27——
Q4 '23$0-$13.0M$-0.29——
Get Your Daily Market Recap